Physician

Philip Elgawli, D.O.

According to 2025 Medicare claims, Philip Elgawli, D.O. (NPI: 1124058102) practices family practice in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Salem, NJ. This provider's primary affiliated billing organization is ELMER FAMILY PRACTICE,PC (NPI: 1275571184; TIN: 010752467) and primary practice location at 08318-2143. Elgawli is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Elgawli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 415 traditional Medicare patients, billed 1,763 HCPCS/CPT codes, and received $114,840 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,910 prescription claims across 570 beneficiaries totaling $665,587 in drug costs, led by Ozempic (Semaglutide). DME data shows 184 claims. Open Payments data shows 1 records totaling $14. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $450,405 to $665,587. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,963 and ending at $13,964.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$71K$141K2015 Medicare payment: $141,242 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $108,664 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $101,124 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $108,312 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $108,912 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $92,674 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $114,218 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $118,582 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $119,693 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $114,840 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154552,452$141,242
20164891,966$108,664
20174772,163$101,124
20184742,095$108,312
20194381,990$108,912
20204021,749$92,674
20214001,717$114,218
20224131,755$118,582
20234071,731$119,693
20244151,763$114,840

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$333K$666K2015 Drug cost: $450,405 (USD; Tot_Drug_Cst)2016 Drug cost: $406,002 (USD; Tot_Drug_Cst)2017 Drug cost: $453,366 (USD; Tot_Drug_Cst)2018 Drug cost: $488,529 (USD; Tot_Drug_Cst)2019 Drug cost: $571,355 (USD; Tot_Drug_Cst)2020 Drug cost: $627,040 (USD; Tot_Drug_Cst)2021 Drug cost: $605,740 (USD; Tot_Drug_Cst)2022 Drug cost: $636,871 (USD; Tot_Drug_Cst)2023 Drug cost: $599,892 (USD; Tot_Drug_Cst)2024 Drug cost: $665,587 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155064,981$450,405
20165294,603$406,002
20175644,834$453,366
20185524,903$488,529
20195365,161$571,355
20205665,734$627,040
20215725,775$605,740
20225445,691$636,871
20235485,773$599,892
20245705,910$665,587

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$7.2K$14K2015 Medicare payment: $3,931 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $3,671 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $14,389 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,122 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,193 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,336 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $371 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,902 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $4,992 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $6,091 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201569255$3,931
201660234$3,671
201713112$14,389
201837151$3,122
201930122$2,193
202012104$1,336
20211144$371
2022N/R78$2,902
2023N/R167$4,992
2024N/R184$6,091

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit240240$137
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more115157$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more214361$60
G0444Annual depression screening, 5 to 15 minutes186186$20
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's138211$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OzempicSemaglutide704,830$152,359
EliquisApixaban673,810$73,493
JardianceEmpagliflozin413,570$65,716
JanuviaSitagliptin Phosphate392,910$49,741
XareltoRivaroxaban231,590$30,008

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R23$1,566
A7032Cushion for use on nasal mask interface, replacement only, eachNN/R11$1,152
A4604Tubing with integrated heating element for use with positive airway pressure deviceNN/R23$862
A7034Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strapNN/R16$798
E0601Continuous positive airway pressure (cpap) deviceYN/R24$700

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$14GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Philip Elgawli, D.O.?

Tedicare shows public-source Medicare data for Philip Elgawli, D.O. (NPI 1124058102), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Philip Elgawli, D.O. have ACO affiliation data?

Philip Elgawli, D.O. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Philip Elgawli, D.O.?

Philip Elgawli, D.O. is linked to ELMER FAMILY PRACTICE,PC (billing NPI 1275571184) in the available physician profile data.

Does Philip Elgawli, D.O. have Open Payments data?

Philip Elgawli, D.O. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.